QUEBEC CITY, Jan. 10 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSX-V: OPS)
announces that it has recently filed a patent application for the
OptoWire, a second diagnostic tool to assess coronary lesions by doing
Fractional Flow Reserve ("FFR").
Opsens' in-house team has been developing the OptoWire in parallel with
the EasyWire, unveiled at the end of December 2010, also for use in
OptoWire for the measurement of FFR
Unlike traditional guide wires, the OptoWire is a guide wire
instrumented with a fiber optic pressure sensor, which is drift free
and provides a high fidelity measurement of blood pressure in coronary
arteries. In addition to more reliable measurement, the OptoWire offers
better mechanical performance in terms of trackability, torquability
and support over other existing pressure guide wires.
"Opsens is developing a complete tool box for cardiologists to use in
the measurement of FFR, allowing them to select the right tool for each
individual patient," said Claude Belleville, VP Medical. "OptoWire and
EasyWire are complementary products: a cardiologist may choose the
OptoWire for a diffused lesion or easy-to-reach lesions, while the
EasyWire may be better suited for lesions that are more difficult to
FFR supported by strong clinical data
Fractional Flow Reserve is an index of the functional severity of a
coronary stenosis that is calculated from pressure measurements taken
before and after a narrowing of the arteries during coronary
arteriography. This new approach enables an "on the spot" diagnosis for
a better assessment as to whether a stent is an appropriate
intervention to improve blood circulation in the cardiovascular system.
FFR measurement is an increasingly popular method used in the treatment
of cardiac lesions. The FAME Study, published in 2009, outlined the
positive outcome this step has on patients' recovery and overall
outcome, reducing death rates by over 30%.
About Opsens Inc. (www.opsens.com)
Opsens is a leading developer, manufacturer and supplier of a wide range
of fiber optic sensors and associated signal conditioners based on
proprietary patented and patent pending technologies. Opsens' sensors
provide long-term accuracy and reliability in the harshest
environments. Opsens provides sensors to measure pressure, temperature,
strain and displacement to original equipment manufacturers (OEM) and
end-users in the oil and gas, medical, and laboratory fields. Opsens
provides complete technical support, including installation, training,
after-sales service, for its fiber optics systems that are regulated by
the ISO 9001-2008 norm.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements contained in this press release involve known
and unknown risks, uncertainties and other factors that may cause
actual results, performance and achievements of Opsens to be materially
different from any future results, performance or achievements
expressed or implied by the said forward-looking statements.
SOURCE OPSENS INC.
For further information:
Pierre Carrier, President and Chief Executive Officer - Tel: 418.682.9996
Louis Laflamme, CA, Chief Financial Officer - Tel: 418.682.9996